Squarepoint’s Sangrix SGRX Stock Holding History
Bought
Maintained
Sold
Other funds holding SGRX
Squarepoint's SGRX Position: Q1 2025 in Review
Squarepoint sold out of Sangrix (SGRX) in Q1 2025, closing a stake of 8 shares — an estimated $19.5K sold.
Squarepoint first reported a position in SGRX in Q4 2019 and held it in 3 quarters. The position peaked at $268K in Q4 2019. 3 funds tracked by Wall St. Rank hold SGRX as of Q1 2025.
- Squarepoint reported no remaining Sangrix position as of Q1 2025 after selling out during the quarter.
- Squarepoint sold 8 Sangrix shares in Q1 2025, an estimated $19.5K.
- Squarepoint first reported a position in Sangrix in Q4 2019 and held it in 3 quarters.
- Squarepoint's Sangrix position peaked at $268K in Q4 2019.
- 3 funds tracked by Wall St. Rank held Sangrix as of Q1 2025.
Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.